2014 | Factors Affecting the Accuracy of Controlled Attenuation Parameter (CAP) in Assessing Hepatic Steatosis in Patients with Chronic Liver Disease
| PLOS ONE |
2022 | Fatty Liver Index Independently Predicts All-Cause Mortality in Patients With Antineutrophil Cytoplasmic Antibody-Associated Vasculitis but No Substantial Liver Disease
| FRONTIERS IN CARDIOVASCULAR MEDICINE |
2021 | Fibrinogen to albumin ratio reflects the activity of antineutrophil cytoplasmic antibody-associated vasculitis
| JOURNAL OF CLINICAL LABORATORY ANALYSIS |
2021 | Frequency and Factors of Indeterminate QuantiFERON-TB Gold In-Tube and QuantiFERON-TB Gold PLUS Test Results in Rheumatic Diseases
| JOURNAL OF CLINICAL MEDICINE |
2020 | Hyperuricemia Is Associated With Decreased Renal Function and Occurrence of End-Stage Renal Disease in Patients With Microscopic Polyangiitis and Granulomatosis With Polyangiitis: A Retrospective Study | RHEUMATOLOGY INTERNATIONAL |
2023 | IL-6 Receptor Expression on the Surface of T Cells and Serum Soluble IL-6 Receptor Levels in Patients with Microscopic Polyangiitis and Granulomatosis with Polyangiitis
| JOURNAL OF CLINICAL MEDICINE |
2017 | In-hospital mortality in febrile lupus patients based on 2016 EULAR/ACR/PRINTO classification criteria for macrophage activation syndrome | SEMINARS IN ARTHRITIS AND RHEUMATISM |
2022 | Incidence and Patterns of Interstitial Lung Disease and Their Clinical Impact on Mortality in Patients with Antineutrophil Cytoplasmic Antibody-Associated Vasculitis: Korean Single-Centre Observational Study
| JOURNAL OF IMMUNOLOGY RESEARCH |
2023 | Incidence of septic arthritis in patients with ankylosing spondylitis and seropositive rheumatoid arthritis following TNF inhibitor therapy | RHEUMATOLOGY |
2020 | Incidence of Tuberculosis in Systemic Necrotizing Vasculitides: A Population-Based Study From an Intermediate-Burden Country
| FRONTIERS IN MEDICINE |
2022 | Incidence, prevalence and risk of stroke in patients with Takayasu arteritis: a nationwide population-based study in South Korea
| STROKE AND VASCULAR NEUROLOGY |
2022 | Interferon-gamma Release Assay Results Are Reliable for Screening for Latent Tuberculosis in Antineutrophil Cytoplasmic Antibody-associated Vasculitis
| IN VIVO |
2020 | Lipid Profiles in Anti-neutrophil Cytoplasmic Antibody-associated Vasculitis: A Cross-sectional Analysis
| Journal of Rheumatic Diseases |
2021 | Male Sex Is a Significant Predictor of All-cause Mortality in Patients with Antineutrophil Cytoplasmic Antibody-associated Vasculitis
| JOURNAL OF KOREAN MEDICAL SCIENCE |
2017 | Malignancies in Korean patients with immunoglobulin G4-related disease | INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES |
2023 | Management of antineutrophil cytoplasmic antibody-associated vasculitis: a review of recent guidelines
| Journal of Rheumatic Diseases |
2020 | Mesenchymal stem cell-derived secretome attenuates nephritis in NZB/W F1 mice by modulating the inflammatory response | Dissertation |
2021 | Metabolic Syndrome Severity Score, Comparable to Serum Creatinine, Could Predict the Occurrence of End-Stage Kidney Disease in Patients with Antineutrophil Cytoplasmic Antibody-Associated Vasculitis
| JOURNAL OF CLINICAL MEDICINE |
2022 | Modified Body Mass Index at Diagnosis is a Useful Predictor of Mortality in Patients With Antineutrophil Cytoplasmic Antibody-associated Vasculitis
| Journal of Rheumatic Diseases |
2018 | Neutrophil to lymphocyte ratio at diagnosis can estimate vasculitis activity and poor prognosis in patients with ANCA-associated vasculitis: a retrospective study
| BMC NEPHROLOGY |
2022 | New body mass index for predicting prognosis in patients with antineutrophil cytoplasmic antibody-associated vasculitis
| JOURNAL OF CLINICAL LABORATORY ANALYSIS |
2023 | New index using triglyceride glucose-body mass index for predicting mortality in patients with antineutrophil cytoplasmic antibody-associated vasculitis
| FRONTIERS IN MEDICINE |
2024 | New-onset atrial fibrillation in seropositive rheumatoid arthritis: association with disease-modifying anti-rheumatic drugs treatment | RHEUMATOLOGY |
2019 | No overlap between IgG4-related disease and microscopic polyangiitis and granulomatosis with polyangiitis despite elevated serum IgG4 at diagnosis: a retrospective monocentric study | CLINICAL RHEUMATOLOGY |
2022 | Nutrition Risk Index Score at Diagnosis Can Effectively Predict Poor Prognosis in Patients With Antineutrophil Cytoplasmic Antibody-Associated Vasculitis | JOURNAL OF RENAL NUTRITION |
2024 | Overlap syndrome of systemic sclerosis with antineutrophil cytoplasmic antibody-associated vasculitis according to 2022 ACR/EULAR criteria
| KOREAN JOURNAL OF INTERNAL MEDICINE |
2021 | Pan-immune-inflammation value at diagnosis independently predicts all-cause mortality in patients with antineutrophil cytoplasmic antibody-associated vasculitis | CLINICAL AND EXPERIMENTAL RHEUMATOLOGY |
2019 | Persistent antiphospholipid antibodies are associated with thrombotic events in ANCA-associated vasculitis: A retrospective monocentric study | NEFROLOGIA |
2023 | Positive faecal immunochemical test predicts the onset of inflammatory bowel disease: A nationwide, propensity score-matched study
| FRONTIERS IN IMMUNOLOGY |
2022 | Predicting the depressive status using empirical dietary inflammatory index in patients with antineutrophil cytoplasmic antibody-associated vasculitis
| JOURNAL OF CLINICAL LABORATORY ANALYSIS |
2021 | Predictive Ability of Serum IL-27 Level for Assessing Activity of Antineutrophil Cytoplasmic Antibody-Associated Vasculitis
| MEDIATORS OF INFLAMMATION |
2023 | Predictive potential of albumin-alkaline phosphatase ratio for cerebrovascular accident in patients with antineutrophil cytoplasmic antibody-associated vasculitis | ANNALS OF CLINICAL BIOCHEMISTRY |
2019 | Predictor of depressive disorders in patients with antineutrophil cytoplasmic antibody-associated vasculitis | CLINICAL RHEUMATOLOGY |
2017 | Predictors of mortality in autoimmune disease patients with concurrent cytomegalovirus infections detected by quantitative real-time PCR.
| PLOS ONE |
2024 | Presence of periodontal disease and the incidence of inflammatory arthritides in the general population: data from the UK Biobank | RHEUMATOLOGY |
2019 | Prognostic nutritional index is associated with disease severity and relapse in ANCA-associated vasculitis | INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES |
2018 | Prognostic nutritional index is correlated with disease activity in patients with systemic lupus erythematosus | LUPUS |
2021 | Reclassification of Korean patients with polymyositis and dermatomyositis based on the Bohan and Peter criteria by the 2017 European League Against Rheumatism/American College of Rheumatology classification criteria for adult and juvenile idiopathic inflammatory myopathies
| KOREAN JOURNAL OF INTERNAL MEDICINE |
2018 | Reclassification of polyarteritis nodosa based on the 1990 ACR criteria using the 2007 EMA algorithm modified by the 2012 CHCC definitions | CLINICAL AND EXPERIMENTAL RHEUMATOLOGY |
2023 | Reclassification of previously diagnosed GPA patients using the 2022 ACR/EULAR classification criteria | RHEUMATOLOGY |
2023 | Renal histopathological predictors of end-stage kidney disease in ANCA-associated vasculitis with glomerulonephritis: a single-centre study in Korea
| SCIENTIFIC REPORTS |
2018 | Renal outcome after kidney-transplantation in Korean patients with lupus nephritis | LUPUS |
2018 | Renal outcome of kidney-transplantation in Korean recipients with ANCA-associated vasculitis
| CLINICAL AND EXPERIMENTAL RHEUMATOLOGY |
2024 | Renal prognosis in patients with new-onset microscopic polyangiitis and granulomatosis with polyangiitis requiring dialysis and potential predictor of renal function recovery
| Journal of Rheumatic Diseases |
2022 | Rheumatoid factor positivity in antineutrophil cytoplasmic antibody-associated vasculitis: a distinct clinical entity or innocent bystander? | RHEUMATOLOGY |
2023 | Risk of cancer, tuberculosis and serious infections in patients with ankylosing spondylitis, psoriatic arthritis and psoriasis treated with IL-17 and TNF-α inhibitors: a nationwide nested case-control analysis
| CLINICAL AND EXPERIMENTAL RHEUMATOLOGY |
2019 | Risk of Cancers in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis: Results from the Korea National Health Insurance Claims Database 2010-2018
| JOURNAL OF CLINICAL MEDICINE |
2021 | Risk of Stroke in Systemic Necrotizing Vasculitis: A Nationwide Study Using the National Claims Database
| FRONTIERS IN IMMUNOLOGY |
2018 | Safety of Tocilizumab in Rheumatoid Arthritis Patients with Resolved Hepatitis B Virus Infection: Data from Real-World Experience
| YONSEI MEDICAL JOURNAL |
2022 | Secular Trends of Incidence, Prevalence, and Healthcare Economic Burden in ANCA-Associated Vasculitis: An Analysis of the 2002-2018 South Korea National Health Insurance Database
| FRONTIERS IN MEDICINE |
2021 | Serological Biomarkers and Indices for the Current Activity and Prognosis of ANCA-Associated Vasculitis: Experience in a Single Centre in Korea
| YONSEI MEDICAL JOURNAL |
2021 | Serum adipokine profiles in patients with microscopic polyangiitis and granulomatosis with polyangiitis: An exploratory analysis
| PLOS ONE |
2022 | Serum albumin, prealbumin, and ischemia-modified albumin levels in patients with ANCA-associated vasculitis: A prospective cohort study
| PLOS ONE |
2018 | Serum aminoacyl-tRNA synthetase-interacting multifunctional protein-1 (AIMP1), a novel disease activity predictive biomarker of systemic lupus erythematosus | CLINICAL AND EXPERIMENTAL RHEUMATOLOGY |
2019 | Serum Aminoacyl-tRNA Synthetase-Interacting Multifunctional Protein-1 Can Predict Severe Antineutrophil Cytoplasmic Antibody-Associated Vasculitis: A Pilot Monocentric Study
| BIOMED RESEARCH INTERNATIONAL |
2020 | Serum Amyloid A Is a Biomarker of Disease Activity and Health-Related Quality-of-Life in Patients with Antineutrophil Cytoplasmic Antibody-Associated Vasculitis
| DISEASE MARKERS |
2021 | Serum chitinase-3-like 1 protein is a useful biomarker to assess disease activity in ANCA-associated vasculitis: an observational study
| ARTHRITIS RESEARCH & THERAPY |
2021 | Serum Clusterin Level Could Reflect the Current Activity of Antineutrophil Cytoplasmic Antibody-Associated Vasculitis
| YONSEI MEDICAL JOURNAL |
2022 | Serum galectin-9 could be a potential biomarker in assessing the disease activity of antineutrophil cytoplasmic antibody-associated vasculitis
| CLINICAL AND EXPERIMENTAL RHEUMATOLOGY |
2022 | Serum glycated albumin as a predictive biomarker for renal involvement of antineutrophil cytoplasmic antibody-associated vasculitis in non-diabetic patients
| BMC NEPHROLOGY |